SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-24-052455
Filing Date
2024-04-26
Accepted
2024-04-26 08:00:33
Documents
15
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2412633d1_10ka.htm   iXBRL 10-K/A 377590
2 EXHIBIT 31.3 tm2412633d1_ex31-3.htm EX-31.3 4133
3 EXHIBIT 31.4 tm2412633d1_ex31-4.htm EX-31.4 4142
  Complete submission text file 0001104659-24-052455.txt   643196

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20231231.xsd EX-101.SCH 3024
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20231231_lab.xml EX-101.LAB 35693
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20231231_pre.xml EX-101.PRE 23376
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2412633d1_10ka_htm.xml XML 6125
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38365 | Film No.: 24878862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)